GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
GlycoMantra received STTR grant from the NCI (NIH)
September 07, 2017
GlycoMantra received STTR grant from the NCI (NIH).
With the University of Maryland Investigator, GlycoMantra was awarded STTR grant to develop a therapeutic for treating head and neck cancer.
